UNICHIP
Dead / Cancelled — Cancelled — Section 8 (as of 17 Dec 2010)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 78131082
- Registration number
- 2840032
- Mark type
- Word mark
- Filed
- 24 May 2002
- Published for opposition
- 29 Jul 2003
- Registered
- 11 May 2004
- Attorney of record
- Stanley C. Macel, III, Esq.
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and veterinarian preparations containing therapeutic proteins, therapeutic nucleicacids, gene and/or cells for health and medical care, namely, for the treatment of allergies, arthritis, cancer, diabetes, diseases of the central nervous system, inflammatory diseases, metabolic disorders, viral diseases; pharmaceutical preparations for use in cardiology and oncology; medical and pharmaceutical products, namely human vaccines, anti-infectives, diagnostic proteins, therapeutic proteins, therapeutic nucleicacids, gene and/or cells; medical, biotechnological and gene-technological products and preparations obtainable by protein-expression-banks and nucleicacid-banks together with expression-vectors, proteomics, proteome-analysis, biochips, comprising proteins and nucleicacids, protein-biochips, arrays for use in or at human beings or animals, namely, proteins; diagnostics and detergents for medical and veterinarian use, namely diagnostic preparations and reagents for clinical or medical laboratory use
- Class 009 — Scientific and electric apparatus: Scientific devices and instruments for the protein-expression in a protein-expression bank, namely, protein-biochips, comprising clones for identification and validation of proteins and encoding nucleicacids together with expression-vectors thereof
- Class 042 — Scientific and technological services: Services for chemical, pharmaceutical, biotechnological, diagnostical, analytical, gene-technological, medical laboratories or industrial facilities or research- and development facilities, namely consulting and analysis in the field of chemistry, pharmacy, biotechnology, diagnostic, analytical, gene-technology, bio-informatics, target validation and drug development, by means of nucleicacid- or protein-biochips, protein-expression-banks, nucleicacid-banks, polypeptide or nucleicacid-libraries and arrays, automation, application and use of protein-biochips; consulting and analysis in the field of automation, application and use of proteomics, proteome studies, proteome designs, peptide and protein analytic and identification, purification and characterization, 1D and 2D gele electrophorese, mass spectrometry, robotics for proteomics and protein-expression-banks
Owner
- Protagen AG, Bochum, DE
- Protagen AG, Bochum, DE
- Protagen AG, Bochum, DE
Prosecution history
- 17 Dec 2010 — CANCELLED SEC. 8 (6-YR)
- 07 Jun 2007 — CASE FILE IN TICRS
- 11 May 2004 — REGISTERED-PRINCIPAL REGISTER
- 04 Feb 2004 — Sec. 1(B) CLAIM DELETED
- 26 Mar 2004 — NOTICE OF ALLOWANCE CANCELLED
- 03 Feb 2004 — FAX RECEIVED
- 21 Oct 2003 — NOA MAILED - SOU REQUIRED FROM APPLICANT
- 29 Jul 2003 — PUBLISHED FOR OPPOSITION
- 09 Jul 2003 — NOTICE OF PUBLICATION
- 21 Apr 2003 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 21 Mar 2003 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 21 Mar 2003 — PAPER RECEIVED
- 29 Sept 2002 — NON-FINAL ACTION E-MAILED
- 24 May 2002 — SEC. 44(D) CLAIM ADDED
- 24 May 2002 — Sec. 1(B) CLAIM ADDED